Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lowering Branched-Chain Amino Acids with Sodium Phenylbutyrate in Type 2 Diabetes
2018-003176-13Phase 4Terminated
- Sponsor
- Maastricht University
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sodium phenylbutyrate in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Maastricht University. Started Nov 2018; status: terminated.
02
Drugs
sodium phenylbutyrate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2018-003176-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003176-13.